Corneal Toxicity Associated With Belantamab Mafodotin Is Not Restricted to the Epithelium: Neuropathy Studied With Confocal Microscopy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Corneal Toxicity Associated With Belantamab Mafodotin Is Not Restricted to the Epithelium: Neuropathy Studied With Confocal Microscopy
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF OPHTHALMOLOGY
Volume 242, Issue -, Pages 116-124
Publisher
Elsevier BV
Online
2022-06-22
DOI
10.1016/j.ajo.2022.06.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium Study
- (2021) Bruce A. Perkins et al. DIABETES CARE
- Corneal in vivo confocal microscopy to detect belantamab mafodotin-induced ocular toxicity early and adjust the dose accordingly: a case report
- (2021) Kevin Marquant et al. Journal of Hematology & Oncology
- Corneal Changes After Belantamab Mafodotin in Multiple Myeloma Patients
- (2020) Rebecca B. Bausell et al. Eye & Contact Lens-Science and Clinical Practice
- EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma
- (2020) Kyriaki Tzogani et al. ONCOLOGIST
- Relapsed refractory multiple myeloma: a comprehensive overview
- (2019) Abdul Hamid Bazarbachi et al. LEUKEMIA
- Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
- (2019) Sagar Lonial et al. LANCET ONCOLOGY
- Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival
- (2018) Ingemar Turesson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy
- (2018) Michael Brines et al. Scientific Reports
- Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial
- (2018) Suzanne Trudel et al. LANCET ONCOLOGY
- The breadth of macropinocytosis research
- (2018) Joel A. Swanson et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Treatment options for relapsed and refractory multiple myeloma
- (2015) A. K. Nooka et al. BLOOD
- Small Nerve Fiber Quantification in the Diagnosis of Diabetic Sensorimotor Polyneuropathy: Comparing Corneal Confocal Microscopy With Intraepidermal Nerve Fiber Density
- (2015) Xin Chen et al. DIABETES CARE
- Normative Values for Corneal Nerve Morphology Assessed Using Corneal Confocal Microscopy: A Multinational Normative Data Set
- (2015) Mitra Tavakoli et al. DIABETES CARE
- Ocular Adverse Events Associated with Antibody–Drug Conjugates in Human Clinical Trials
- (2015) Joshua Seth Eaton et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Concise Review: Identifying Limbal Stem Cells: Classical Concepts and New Challenges
- (2013) Aaron W. Joe et al. Stem Cells Translational Medicine
- Drug-conjugated antibodies for the treatment of cancer
- (2012) John M. Lambert BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Repeatability of In Vivo Corneal Confocal Microscopy to Quantify Corneal Nerve Morphology
- (2012) Ioannis N. Petropoulos et al. CORNEA
- Macropinocytosis: an endocytic pathway for internalising large gulps
- (2011) Jet Phey Lim et al. IMMUNOLOGY AND CELL BIOLOGY
- Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging
- (2011) M.A. Dabbah et al. MEDICAL IMAGE ANALYSIS
- Cytosine-Arabinoside-Induced Keratopathy: A Model of Corneal Proliferation Kinetics
- (2010) Tanja Guthoff et al. OPHTHALMOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now